Immunome IMNM Balance Sheet (2019-2026)

NASDAQ IMNM
$26.75 -0.41 (-1.51%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Immunome Quarterly Balance Sheet

Periods 28 quarters
Latest Jun 2026

Immunome reported total assets of $565.38M and total liabilities of $40.30M for the quarter ended Jun 2026, up 90.8% year over year. This balance sheet covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
56.24M49.23M42.88M34.65M27.08M20.32M44.42M38.42M90.64M98.68M269.72M165.33M155.57M143.35M257.61M143.88M272.64M653.48M582.70M217.71M
Short-term InvestmentsInvestments (Current)
39.46M40.00M113.02M84.60M73.95M59.71M124.20M302.30M
Cash & Current Investments
56.24M49.23M42.88M34.65M27.08M20.32M44.42M38.42M90.64M138.14M309.72M278.35M240.17M217.30M317.32M268.08M272.64M653.48M582.70M520.01M
Receivables - OtherOther Receivables
0.20M17.40M0.85M0.85M0.82M0.21M0.29M
Prepaid Assets
4.95M7.41M3.42M2.95M2.16M2.33M2.11M1.11M0.77M6.56M3.62M5.93M3.91M4.04M5.81M9.40M7.29M7.29M11.62M18.45M
Current Assets
61.19M56.64M46.30M37.60M29.24M22.65M46.54M39.53M91.41M144.70M313.33M284.28M244.04M221.34M323.13M277.43M279.92M660.78M594.31M538.45M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.96M0.85M0.75M0.81M0.70M0.68M0.92M1.20M1.17M2.07M4.30M6.10M7.17M10.11M10.95M11.03M11.56M14.64M17.08M17.36M
Other Non-Current Assets
0.10M0.33M0.10M0.10M0.10M0.33M0.10M0.10M0.10M0.10M0.10M0.10M0.10M4.41M0.10M0.21M4.55M4.59M5.36M5.42M
Non-Current Assets
1.37M1.29M1.43M1.42M1.31M1.40M1.58M1.91M1.75M3.84M6.43M11.93M12.86M18.90M19.56M18.86M19.45M22.41M25.48M26.93M
Assets
62.56M57.92M47.73M39.02M30.55M24.05M48.11M41.44M93.16M148.54M319.75M296.21M256.90M240.24M342.69M296.29M299.38M683.19M619.79M565.38M
Liabilities
Current Liabilities
Accounts Payables
3.28M3.08M3.89M5.26M3.14M2.40M3.31M3.70M2.79M3.31M7.18M7.05M3.52M14.19M9.13M4.66M6.15M3.34M5.53M6.00M
Payables
3.28M3.08M3.89M5.26M3.14M2.40M3.31M3.70M2.79M3.31M7.18M7.05M3.52M14.19M9.13M4.66M6.15M3.34M5.53M6.00M
Accumulated Expenses
4.47M6.65M5.82M3.36M4.23M4.93M3.31M5.03M3.37M8.03M10.84M20.26M26.33M33.18M17.66M18.22M25.30M41.65M21.88M29.72M
Other Accumulated Expenses
2.52M1.25M3.97M2.21M2.51M2.26M1.99M1.98M0.71M1.79M6.45M14.46M18.08M7.98M12.46M10.56M15.59M3.63M3.17M3.23M
Short term Debt
Current Leases
0.31M0.26M0.06M0.15M
Current Deferred Revenue
18.21M17.67M16.96M10.49M12.74M12.59M9.68M6.94M4.01M
Total Current Liabilities
7.76M9.73M9.71M8.62M7.37M7.33M24.83M26.39M23.11M21.83M30.77M39.90M39.53M54.31M30.80M22.88M31.45M44.99M27.41M35.71M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue
0.01M0.01M9.42M5.71M2.85M5.49M2.21M
Preferred Stock Liabilities
Operating Leases
1.34M1.34M1.21M2.48M2.46M4.77M4.77M4.14M4.01M3.85M3.69M4.59M
Other Non-Current Liabilities
0.01M0.15M0.12M0.09M0.06M0.12M1.34M
Total Non-Current Liabilities
9.73M9.71M8.62M7.37M7.33M86.96M27.32M
Total Liabilities
7.76M9.74M9.85M8.74M7.46M7.39M34.25M32.10M87.08M28.66M34.18M42.38M41.99M59.08M35.57M27.02M35.46M48.84M31.11M40.30M
Shareholder's Equity
Total Debt
Common Equity
54.79M48.19M37.87M30.28M23.08M16.65M13.86M9.34M6.08M119.88M285.57M253.84M214.91M181.16M307.13M269.27M263.92M634.34M588.69M525.08M
Liabilities and Shareholders Equity
62.56M57.92M47.73M39.02M30.55M24.05M48.11M41.44M93.16M148.54M319.75M296.21M256.90M240.24M342.69M296.29M299.38M683.19M619.79M565.38M
Retained Earnings
126.05M127.29M128.63M129.96M131.30M132.65M134.13M135.16M136.25M342.66M637.86M642.25M650.35M696.87M864.53M870.09M922.17M1,362.50M1,370.68M1,380.54M
Treasury Shares